Skip to content

13F-HR filed by Lion Point Capital, LP

Lion Point Capital, LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 19 holding rows worth $19,099,206.

Accession
0001013594-25-000268
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 19 entries on the cover page, a total value of $19,099,206 stated on the cover page (in dollars after the unit check, H1), rows summing to $19,099,206 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INSMED INC COM PAR $.01457669307Stock36,700$2,533,768dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
Milestone Pharmaceuticals Inc59935V107COM1,025,806$2,420,902dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
GERON CORP374163103COM500,000$1,770,000dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ARDELYX INC039697107COM335,400$1,700,478dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK195,700$1,236,824dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
BRIDGEBIO PHARMA INC10806X102COM40,300$1,105,832dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
MINERALYS THERAPEUTICS INC603170101COM79,000$972,490dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL AG52694109Stock45,900$907,902dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
BIOHAVEN LTDG1110E107COM22,700$847,845dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
BENITEC BIOPHARMA INC08205P209COMMON STOCK62,000$783,060dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SYNDAX PHARMACEUTICALS INC87164F105COM55,000$727,100dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
JASPER THERAPEUTICS INC471871202COM NEW32,000$684,160dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
AVADEL PHARMACEUTICALS PLCG29687103COM SHS64,000$672,640dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
DISC MEDICINE INC COM254604101Stock10,600$672,040dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
BLUEBIRD BIO INC COM NEW09609G209Stock78,912$658,126dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ARCUTIS BIOTHERAPEUTICS INC03969K108COM46,300$644,959dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
REGENXBIO INC75901B107COM57,750$446,408dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SERES THERAPEUTICS INC81750R102COM340,761$283,172dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SPRUCE BIOSCIENCES INC85209E109COM75,000$31,500dollars as filedThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001013594-25-000268this filing2025-02-14acceptance time not in the bulk data set